Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, 72205, USA.
Alcohol. 2010 Mar;44(2):157-69. doi: 10.1016/j.alcohol.2009.11.002. Epub 2010 Jan 29.
The importance of ethanol metabolism in the development of alcoholic liver disease remains controversial. The present study examined the effects of selective inhibition of the cytochrome P450 enzyme CYP2E1 compared with the inhibition of overall ethanol metabolism on the development of alcoholic steatohepatitis. Adult male Sprague-Dawley rats were fed via total enteral nutrition for 45 days with or without 10-12g/kg/d ethanol. Some groups were given 200mg/kg/d of the CYP2E1 inhibitor diallyl sulfide (DAS). Other groups were treated with 164mg/kg/d of the alcohol dehydrogenase (ADH) inhibitor 4-methylpyrazole (4-MP) and dosed at 2-3g/kg/d ethanol to maintain similar average urine ethanol concentrations. Liver pathology scores and levels of apoptosis were elevated by ethanol (P<.05) but did not differ significantly on cotreatment with DAS or 4-MP. However, liver triglycerides were lower when ethanol-fed rats were treated with DAS or 4-MP (P<.05). Serum alanine aminotransferase values were significantly lower in ethanol-fed 4-MP-treated rats indicating reduced necrosis. Hepatic oxidative stress and the endoplasmic reticulum (ER) stress marker tribbles-related protein 3 were increased after ethanol (P<.05); further increased by DAS but partly attenuated by 4-MP. Both DAS and 4-MP reversed ethanol increases in the cytokine, tumor necrosis factor-alpha (TNF-alpha), and the chemokine CXCL-2 (P<.05). However, neither inhibitors prevented ethanol suppression of interleukins IL-4 or IL-12. Moreover, neither inhibitors prevented ethanol increases in tumor growth factor-beta mRNA. Ethanol and DAS additively induced hepatic hyperplasia (P<.05). These data suggest that a significant proportion of hepatic injury after ethanol exposure is independent of alcohol metabolism. Ethanol metabolism by CYP2E1 may be linked in part to triglyceride accumulation, to induction of TNF-alpha, and to chemokine production. Ethanol metabolism by ADH may be linked in part to oxidative and ER stress and necrotic injury.
乙醇代谢在酒精性肝病发展中的重要性仍存在争议。本研究比较了选择性抑制细胞色素 P450 酶 CYP2E1 与抑制整体乙醇代谢对酒精性脂肪性肝炎发展的影响。成年雄性 Sprague-Dawley 大鼠通过全肠内营养喂养 45 天,给予或不给予 10-12g/kg/d 乙醇。一些组给予 200mg/kg/d 的 CYP2E1 抑制剂二烯丙基二硫化物(DAS)。其他组给予 164mg/kg/d 的乙醇脱氢酶(ADH)抑制剂 4-甲基吡唑(4-MP),并给予 2-3g/kg/d 乙醇以维持相似的平均尿液乙醇浓度。乙醇可使肝组织病理学评分和细胞凋亡水平升高(P<.05),但与 DAS 或 4-MP 联合治疗时差异无统计学意义。然而,当用 DAS 或 4-MP 治疗乙醇喂养的大鼠时,肝甘油三酯水平降低(P<.05)。血清丙氨酸氨基转移酶值在乙醇喂养的 4-MP 治疗大鼠中明显较低,表明坏死减少。肝氧化应激和内质网(ER)应激标志物 tribbles 相关蛋白 3 在乙醇后增加(P<.05);DAS 进一步增加,但 4-MP 部分减弱。DAS 和 4-MP 均逆转了乙醇对细胞因子肿瘤坏死因子-α(TNF-α)和趋化因子 CXCL-2 的增加(P<.05)。然而,两种抑制剂均不能防止乙醇对白细胞介素 IL-4 或 IL-12 的抑制作用。此外,两种抑制剂均不能防止乙醇增加肿瘤生长因子-β mRNA。乙醇和 DAS 相加诱导肝增生(P<.05)。这些数据表明,暴露于乙醇后,肝脏损伤的相当一部分与酒精代谢无关。CYP2E1 代谢的乙醇可能部分与甘油三酯积累、TNF-α诱导和趋化因子产生有关。ADH 代谢的乙醇可能部分与氧化应激和 ER 应激及坏死性损伤有关。